<DOC>
	<DOCNO>NCT01341197</DOCNO>
	<brief_summary>Fecal occult blood test ( FOBT ) convenient tool screen asymptomatic gastrointestinal ( GI ) bleed 「guaiac-based fecal occult test ( G-FOBT ) 」 increasingly replace use 「immunochemical-based test ( I-FOBT ) 」 reacts human globin , protein digest upper GI enzyme specific detect low GI bleeding . However , Taiwan , although incidence colorectal cancer rapidly increase , Helicobacter pylori-related upper GI pathology remain highly prevalent , may imply mass screen solely base I-FOBT could insufficient significant upper GI pathology miss . Since I-FOBT dose predict upper GI pathology , adjuncts G-FOBT H. pylori stool-antigen test ( HpSA ) may potential candidate realize pan-detecting assay base stool sample population low upper GI lesion equally prevalent .</brief_summary>
	<brief_title>Fecal Screening Assay Taiwanese Population</brief_title>
	<detailed_description>Background objective : Fecal occult blood test ( FOBT ) convenient tool screen asymptomatic gastrointestinal ( GI ) bleed 「guaiac-based fecal occult test ( G-FOBT ) 」 increasingly replace use 「immunochemical-based test ( I-FOBT ) 」 reacts human globin , protein digest upper GI enzyme specific detect low GI bleeding . However , Taiwan , although incidence colorectal cancer rapidly increase , Helicobacter pylori-related upper GI pathology remain highly prevalent , may imply mass screen solely base I-FOBT could insufficient significant upper GI pathology miss . Since I-FOBT dose predict upper GI pathology , adjuncts G-FOBT H. pylori stool-antigen test ( HpSA ) may potential candidate realize pan-detecting assay base stool sample population low upper GI lesion equally prevalent . Patients : Our study enroll consecutive subject participate health check-up National Taiwan University Hospital ( Health Management Center ) , undergo I-FOBT , G-FOBT , HpSA , colonoscopy EGD . The diagnostic value three fecal test , alone combination , respectively evaluate . know subject detect gastrointestinal tract cancer might small base one screen setting , also recruit patient detected gastrointestinal tract cancer screen site refer National Taiwan University Hospital confirmatory diagnosis treatment . They also request complete three fecal test well bidirectional endoscopy ; however , note , group patient , complete one bidirectional endoscopy still eligible . Our primary hypothesis test whether guaiac-based test combine immunochemical test could help differentiate occult bleed upper gastrointestinal tract lower gastrointestinal tract . As hypothesis would hold , also evaluate alternative choice base Helicobacter pylori stool antigen test catch upper gastrointestinal tract lesion .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>subject receive three fecal test receive confirmatory endoscopic diagnosis subject overt gastrointestinal bleeding ( e.g. , hematemesis , tarry stool , melena , hematochezia ) would normally push patient seek immediate health care instead participate screen program . subject receive fecal test subject receive confirmatory endoscopic diagnosis subject undergone gastrectomy colectomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Fecal immunochemical test</keyword>
	<keyword>Guaiac fecal occult blood test</keyword>
	<keyword>Helicobacter pylori stool antigen test</keyword>
	<keyword>Mass screening</keyword>
	<keyword>Bidirectional endoscopy</keyword>
</DOC>